CORAL GABLES, Fla., Nov. 3, 2023 /PRNewswire/ -- Relmada Therapeutics, Inc. (Nasdaq: RLMD), a late-stage biotechnology company addressing diseases of the central nervous system (CNS), today announced that it will report its financial results for the third quarter ended September 30, 2023 after ...
COLUMBUS, Ohio (AP) 鈥� Abortion access is expected to play a central role in the 2024 elections. The preview comes next week, when Ohio voters decide whether to enshrine reproductive rights in their state Constitution.<a ...
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Nov 3, 2023--Ankyra Therapeutics, an emerging clinical stage biotechnology company pioneering anchored immunotherapies to treat cancer, today announced data from a preclinical study using ANK-101, an IL-12 anchored therapeutic, in combination with cytotoxic ...
CHICAGO--(BUSINESS WIRE)--Nov 3, 2023--Tempus, a leader in artificial intelligence and precision medicine, today announced <a ...
INDIANAPOLIS, Ind. (AP) 鈥� Indiana's attorney general violated professional conduct rules in statements he made about a doctor who provided an abortion to a <a href="https://apnews.com/article/abortion-biden-indiana-newspapers-938874e6b63b13e17f9d6f153915ec08">10-year-old rape ...
LAS VEGAS--(BUSINESS WIRE)--Nov 3, 2023--<em>SAWC</em> 鈥� <a ...
